Learning Disabilities Research Centers (P50 Clinical Trial Optional)

The summary for the Learning Disabilities Research Centers (P50 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Learning Disabilities Research Centers (P50 Clinical Trial Optional): The Eunice Kennedy ShriverNational Institute of Child Health and Human Development (NICHD) invites center applications for the Learning Disabilities Research Centers Program, hereafter termed LDRCs. The LDRCs initiative focuses on generating new scientific knowledge to inform understanding of specific learning disorders (SLDs) and comorbid conditions through synergistic, integrated, team-based transdisciplinary science. This funding opportunity announcement invites both foundational and translational, transdisciplinary research addressing the definition, classification, etiology, diagnosis, epidemiology, early identification, prevention-based approaches, and remediation of children, adolescents, or young adults identified with or at risk for SLDs in component oral language abilities, reading, written expression abilities, mathematics and relationships among these SLDs and other disabilities and co-occurring or comorbid conditions. The LDRCs provide a unique platform to engage with external research and community members in purposeful, sustained bidirectional communication and provide career enhancing opportunities for early career investigators expanding their reach and impact.

Federal Grant Title:	Learning Disabilities Research Centers (P50 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HD-23-022
Type of Funding:	Grant
CFDA Numbers:	93.865
CFDA Descriptions:	Information not provided
Current Application Deadline:	December 29th, 2022
Original Application Deadline:	December 29th, 2022
Posted Date:	October 7th, 2022
Creation Date:	October 7th, 2022
Archive Date:	February 3rd, 2023
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	October 7th, 2022

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-022.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical...; • Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial No...; • Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P5...; • Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional...; • Early Immune System Development and Ontogeny (R01 Clinical Trial Optional); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiologi...; • Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required); • Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not ...; • Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required); • Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P5...